Viking Therapeutics (VKTX) has been on a wild ride this year, with shares sliding over the past month even after a massive run in the past 3 years. So what is the market rethinking here? See our ...

Viking Therapeutics Inc. (NASDAQ:VKTX) is one of the stocks that will double in 2026. Earlier on November 12, Canaccord ...

We came across a bullish thesis on Viking Therapeutics, Inc. on Alpha Talon Investment Research’s Substack by AT Investment ...

Eli Lilly (NYSE:LLY) is rapidly establishing itself as the leader in GLP-1 treatments for weight loss. Its Zepbound injection ...

For those willing to take a chance, let's consider two biotech stocks that could eventually become solid, well-established drugmakers: CRISPR Therapeutics(NASDAQ: CRSP) and Viking Therapeutics(NASDAQ: ...

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $36.15, marking a -2.51% move from the previous day. This move lagged the S&P 500's daily loss of 0.16%. Meanwhile, the Dow ...

Upstart biotech company Viking Therapeutics (NASDAQ: VKTX) is a potential takeover candidate in 2026. That's not a reason to ...

We recently published 7 Best ASX Stocks to Buy Right Now. Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the best ASX stocks. Telix Pharmaceuticals Limited (NASDAQ:TLX) is a biotechnology ...

Altimmune (ALT) stock is in focus as the company announces data from a mid-stage trial for its MASH therapy pemvidutide ...

Sanofi sees continued growth and strong financials despite a pipeline setback. Click for this updated look at SNY stock ...

These stocks have promising assets in their portfolios that could help make their valuations soar in the future.

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, ...